Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. Summary
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
380(c) 377(c) 369.5(c) 363.5(c) 354.5 Last
201 405 49 891 116 656 252 832 28 490 Volume
-2.56% -0.79% -1.99% -1.62% -2.48% Change
More quotes
Financials (USD)
Sales 2021 11,2 M - -
Net income 2021 -131 M - -
Net cash position 2021 424 M - -
P/E ratio 2021 -11,7x
Yield 2021 -
Sales 2022 9,08 M - -
Net income 2022 -147 M - -
Net cash position 2022 329 M - -
P/E ratio 2022 -2,70x
Yield 2022 -
Capitalization 1 466 M 1 467 M -
EV / Sales 2021 93,2x
EV / Sales 2022 125x
Nbr of Employees 250
Free-Float 84,3%
More Financials
Company
PureTech Health PLC is a clinical stage biotechnology company. The Company is engaged in discovering, developing and commercializing medicines for diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders, and inflammatory and immunological diseases, among others. Its segments include Internal and Affiliates. The Internal division is focused on advancing a... 
Read more
More about the company
Ratings of PureTech Health plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PURETECH HEALTH PLC
05/27PURETECH HEALTH  : Results of Annual General Meeting (Form 6-K)
PU
05/27PURETECH HEALTH  : Founded Entity Gelesis Presents Findings on Plenity®-Induced ..
BU
05/26PURETECH HEALTH  : Akili Interactive Secures $160 Million in Financing
MT
05/26PURETECH HEALTH  : Founded Entity Akili Secures $160 Million in Financing; Poise..
BU
05/25PURETECH HEALTH  :  to Present at the Jefferies Virtual Healthcare Conference
BU
05/12PURETECH HEALTH  : Forms Clinical Advisory Board for Idiopathic Pulmonary Fibros..
BU
04/28PURETECH HEALTH  : Announces Preclinical Data on Potential Alzheimer's Disease T..
MT
04/28PURETECH HEALTH  : Announces Nature Publication Supporting Modulation of Meninge..
BU
04/26PURETECH HEALTH  : Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane..
BU
04/15VEDANTA BIOSCIENCES  : to Present at the 2021 Jefferies Virtual Microbiome-Based..
BU
04/15PURETECH HEALTH  : FY20 Profit Sinks On Lower Deconsolidation Gain, Influence
MT
04/15PURETECH HEALTH  : Earnings Flash (PRTC.L) PURETECH HEALTH Posts FY20 EPS $0.02
MT
04/15PURETECH HEALTH  : Earnings Flash (PRTC.L) PURETECH HEALTH Reports FY20 Revenue ..
MT
04/15PURETECH HEALTH  : Announces Annual Results for Year Ended December 31, 2020
BU
04/12PURETECH HEALTH  : Presents Promising Preclinical Data from LYT-210 Immuno-Oncol..
BU
More news
News in other languages on PURETECH HEALTH PLC
04/16STOCK MARKET PARIS : La croissance chinoise s'invite chez les sorcières
04/16AVIS D'ANALYSTES DU JOUR  : Safran, Publicis, Nestlé, Volkswagen, Siemens, Givau..
2020AVIS D'ANALYSTES DU JOUR  : BNP Paribas, LVMH, L'Oréal, Vallourec, Nexans, Sunri..
2020STOCK MARKET PARIS : Coronavirus, peur sur l'économie
2018ERRATA CORRIGE : Pubblicati sulla rivista Obesity i dati principali sulla perdit..
More news
Analyst Recommendations on PURETECH HEALTH PLC
More recommendations
Chart PURETECH HEALTH PLC
Duration : Period :
PureTech Health plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 9,17 $
Last Close Price 5,12 $
Spread / Highest target 151%
Spread / Average Target 79,2%
Spread / Lowest Target 37,4%
EPS Revisions
Managers and Directors
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Secretary & Executive Director
George Farmer Chief Financial Officer
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC-9.13%1 467
MODERNA, INC.92.96%83 281
LONZA GROUP AG16.84%54 908
IQVIA HOLDINGS INC.37.73%46 855
CELLTRION, INC.-23.40%34 341
SEAGEN INC.-12.48%28 363